Synopsis of recent research by authors named "Charalambos Gogos"
- Charalambos Gogos's recent research primarily focuses on the implications of infectious diseases in special populations, particularly concerning the clinical outcomes of patients with HIV, chronic liver diseases, and other vulnerabilities in the context of SARS-CoV-2 variants and related complications during the COVID-19 pandemic.
- His studies reveal significant findings about the economic burden of bloodstream infections, patterns of macrophage activation syndrome in viral sepsis, and the risk factors associated with hepatitis E among HIV-infected individuals, underscoring the need for tailored treatment and monitoring strategies in these groups.
- Gogos's work also emphasizes the impact of antimicrobial resistance, frailty, and the management of COVID-19 pharmacotherapy, illustrating the challenges faced by healthcare systems while providing insights into optimal therapeutic approaches and public health policies.
